Concepedia

John J. Osborne

JJ

Statistics

Publications

10

Citations

540

H-Index

10

Active since

1968

Affiliations

Eli Lilly (United States)(Current)

John J. Osborne is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and medicinal chemistry.

Publications per year

1968–2017

10

Publications

10

The Changing Landscape for Stroke Prevention in AF

Menno V. Huisman, Kenneth J. Rothman, Miney Paquette et al. · Journal of the American College of Cardiology · 2017 · 281 citations · Full text

, , +10

Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist

Yanping Xu, Daniel Mayhugh, Ashraf Saeed et al. · Journal of Medicinal Chemistry · 2003 · 61 citations · Full text

, , +13

Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity

Jeffrey A. Dodge, Charles W. Lugar, Stephen Cho et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1997 · 55 citations

, , +10

Vasorelaxant and second messenger effects of maxadilan.

Suzanne A. Grevelink, John J. Osborne, J Loscalzo et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 28 citations

, , +8

Design and Synthesis of Dual Peroxisome Proliferator-Activated Receptors γ and δ Agonists as Novel Euglycemic Agents with a Reduced Weight Gain Profile

Yanping Xu, Garret J. Etgen, Carol L. Broderick et al. · Journal of Medicinal Chemistry · 2006 · 26 citations · Full text

, , +17

1–5 of 10